Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins-Reference-Cited by-同舟云学术

Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins

Published:2017-02-13 Issue:4 Volume:18 Page:464-473
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Nachbagauer Raffael^ORCID,Choi Angela,Hirsh Ariana,Margine Irina,Iida Sayaka,Barrera Aldo,Ferres Marcela,Albrecht Randy A^ORCID,García-Sastre Adolfo,Bouvier Nicole M,Ito Kimihito,Medina Rafael A,Palese Peter,Krammer Florian

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/ni.3684.pdf

Reference45 articles.

1. Jayasundara, K., Soobiah, C., Thommes, E., Tricco, A.C. & Chit, A. Natural attack rate of influenza in unvaccinated children and adults: a meta-regression analysis. BMC Infect. Dis. 14, 670 (2014).

2. Krammer, F. & Palese, P. Advances in the development of influenza virus vaccines. Nat. Rev. Drug Discov. 14, 167–182 (2015).

3. Horimoto, T. & Kawaoka, Y. Influenza: lessons from past pandemics, warnings from current incidents. Nat. Rev. Microbiol. 3, 591–600 (2005).

4. Wrammert, J. et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208, 181–193 (2011).

5. Pica, N. et al. Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proc. Natl. Acad. Sci. USA 109, 2573–2578 (2012).

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine-induced NA immunity decreases viral shedding, but does not disrupt chains of airborne transmission for the 2009 pandemic H1N1 virus in ferrets;mBio;2024-09-09

2. Cross-protection against influenza viruses by chimeric M2e-H3 stalk protein or multi-subtype neuraminidase plus M2e virus-like particle vaccine in ferrets;Virology;2024-07

3. Increased efficacy of influenza virus vaccine candidate through display of recombinant neuraminidase on virus like particles;Frontiers in Immunology;2024-06-10

4. Inactivated influenza virus vaccines expressing COBRA hemagglutinin elicited broadly reactive, long-lived protective antibodies;Human Vaccines & Immunotherapeutics;2024-06-02

5. The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017;eLife;2024-05-28